A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome

Clinical trial NCT00508157 · TERMINATED

Trial details

NCT number: NCT00508157
Sponsor: Bristol-Myers Squibb
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Metabolic Syndrome Schizophrenia

Start date: 2007-11-01
Primary completion: 2009-03-01
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.